letermovir
letermovir: 4 clinical trials tracked.
letermovir evidence translation
What we can confirm
4 tracked trials
What it means
What to watch
Prepared research question
What is verified about letermovir, and what remains unknown?
Traceable citations · Unknowns marked
See linked entities and source evidence6 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Clinical Trial Registry Records (4)
An Interventional Study of Letermovir for Primary Prophylaxis of Cytomegalovirus Infection in Moderate Risk (R+) Abdominal Solid Organ Transplant Recipients
Primary endpoint: Efficacy of letermovir as a prophylaxis of CMV
A Phase 1b Trial of CMV-MVA Triplex Vaccine in Haploidentical Stem Cell Donors and Recipients to Enhance CMV-Specific Immunity and Prevent CMV Viremia in Recipients of Hematopoietic Stem Cell Transplant
Primary endpoint: Cytomegalovirus (CMV) reactivation prompting antiviral therapy
A Phase 1, Open-label, Single-arm Study to Evaluate the Pharmacokinetics and Safety of Letermovir in Pediatric Kidney Transplant (KT) Recipients Less Than 18 Years of Age and Weighing Less Than 40 Kilograms
Primary endpoint: Area Under the Curve From Time 0 to 24 Hours (AUC0-24)
Letermovir Prophylaxis for Cytomegalovirus in Pediatric Hematopoietic Cell Transplantation
Primary endpoint: Clinically significant cytomegalovirus (CMV) infection